Feb 23 (Reuters) - Drug developer Generate Biomedicines
said on Monday it was aiming to raise as much as $425 million in
its initial public offering in the United States.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by
Shilpi Majumdar)